WEAU | Eau Claire, Wisconsin | News, Weather, & Sports

FDA advisers unanimously back J&J hepatitis C drug

By: AP Email
By: AP Email

SILVER SPRING, Md. (AP) -- An experimental hepatitis C drug from Johnson & Johnson has won unanimous support from government experts who say the medication should be approved to treat patients infected with the liver-destroying virus.

All 19 members of a panel of Food and Drug Administration advisers voted unanimously in favor of approving J&J's simeprevir, a daily pill designed to eliminate the most common form of hepatitis C.

The FDA is not required to follow the group's recommendation, though it often does. A decision on the drug is expected next month.

More than 3 million people in the U.S. have hepatitis C, a blood-borne disease that causes liver damage and is blamed for 15,000 deaths a year. J&J is one of a half-dozen companies working to develop more effective treatments for the virus.


Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
WEAU 13 NEWS 1907 S. Hastings Way Eau Claire, WI 54701 By Phone: Main Number (715) 835-1313 and (715) 832-3474. Tip Line (715) 839-WEAU - (715) 839-9328 Sports Line (715) 852-1537
Gray Television, Inc. - Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 229156861